icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research icrowd research

Gout Market Size Is Expected To Register A CAGR Of 11.75% To Reach USD 11.13 billion By 2032 | MRFR

Oct 11, 2023 1:05 PM ET

Gout Market Size Is Expected To Register A CAGR Of 11.75% To Reach USD 11.13 billion By 2032 | MRFR

Gout Market Research Report Information By Treatment and Diagnosis (Diagnosis, Treatment (NSAIDs, Corticosteroids, Colchicine, Urate-Lowering Agents, Others)), Application (Acute Gout, Chronic Gout), End User (Hospitals & Clinics, Specialty Centers, Others) and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2032

Market Overview

Market Research Future (MRFR) ‘s report highlights The gout market is projected to grow from USD 5.07 billion in 2023 to USD 11.13 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 11.75% during the forecast period (2023 – 2032).

Market Synopsis

Some patients with high uric acid levels experience the onset of gout, an inflammatory form of arthritis. A joint may develop needle-like crystals from the acid, resulting in abrupt, intense episodes of swelling, soreness, redness, and pain. The most prevalent type of inflammatory arthritis, gout, is characterized by frequent, incapacitating, excruciatingly painful bouts. It results from urate crystals building up in and around the joints due to hyperuricemia. Antigout drugs are another name for anti-hyperuricemic drugs. Anti-hyperuricemic drugs reduce blood uric acid levels by hastening uric acid’s elimination through the urine or by stopping the formation of excess uric acid. As the geriatric population grows and living habits change, it is anticipated that the prevalence of gout will increase. Urate crystal deposits in and around the joints may develop over time due to elevated uric acid levels in the blood. White blood cells may be drawn to these crystals, resulting in agonizing gout attacks and persistent arthritis.

Get Free Sample PDF Brochure @

As a result, the prevalence of gout is predicted to raise the need for medications to treat the ailment spur market expansion throughout the projection period. Gout treatments are available, but therapy should be personalized for each patient. Options for treatment vary depending on renal function, other health conditions, personal preferences, and other elements. Patients may require medicine to lessen their high blood uric acid levels, which increases their risk of developing gout. Short-acting NSAIDs taken in high doses offer the quickest symptom alleviation. Although these medications can potentially induce stomach discomfort, ulcers, or diarrhea, most users take them well when taking them for a brief amount of time. Urate-lowering medications are used as a first-line treatment or in combination therapy to treat the symptoms of gout arthritis.

Market Competitive Landscape:

  • Novartis AG (Switzerland)
  • Takeda Pharmaceutical Company Limited (Japan)
  • GlaxoSmithKline plc (UK)
  • Regeneron Pharmaceuticals, Inc (US)
  • Teijin Limited (Japan)
  • Viatris Inc (US)
  • Lannett (US)
  • Horizon Therapeutics plc (US)
  • Boehringer Ingelheim International GmbH (Germany)
  • ROMEG Therapeutics, LLC (US)

Market U.S.P. Covered:

Market Drivers:

The market is expected to grow due to factors including increasing biologic adoption, increased regenerative medicine research and development, rising gout prevalence due to increased alcohol consumption, and advancements in imaging techniques that have improved our understanding of gout. Numerous studies have demonstrated that primary care gout management is insufficient, which may be a factor in the growth in the prevalence of clinically severe symptomatic gout. In the UK and Germany, gout patients were shown to have obesity, diabetes, and hypertension frequently. Since aging in the population increases risk factors, gout is anticipated to become more common.

The prevalence of complicated gout patients, particularly secondary gout, is increasing in hospital settings, and this trend may have an impact on the size of the global market for gout therapies. Over the projected period, the global market for gout disease treatment is anticipated to rise due to rising pipeline research to create novel anti-gout medications. The market for treating gout illness is additionally anticipated to rise due to increased product approvals by regulatory bodies. Since most gout medications have serious adverse effects, there should be less demand for them. Nonsteroidal anti-inflammatory medicines (NSAIDs) can lead to indigestion and other gastrointestinal issues. In rare instances, these medications can result in gastrointestinal rashes, bleeding, and stomach ulcers.

Additionally, it is anticipated that side effects like intolerance and contraindication will restrict the use of these medications for treating gout. Obesity, nutritional habits, concurrent illnesses, and novel connections of gout with other comorbidities, including erection problems, ventricular fibrillation, obstructive slumber apnea, osteoporosis, and venous thromboembolism, were identified as additional risk factors for developing gout.

Market Segmentation

The market includes NSAIDS, corticosteroids, colchicine, and urate-lowering medications under the headings of treatment and diagnosis. The market offers both chronic and acute gout, according to application. The market encompasses hospitals, clinics, specialized centers, and other end users.

Browse In-depth Market Research Report (128 Pages) on Gout:

Regional Insights

Due to the rising prevalence of gout, the region’s developed healthcare infrastructure, and rising healthcare costs, North America is anticipated to hold the lion’s share of the global market for gout therapies over the forecast period. The U.S.’s expanding comorbidity burden and rising incidence of gout are projected to drive the market in the area throughout the projection period. The most prevalent inflammatory arthritis in the nation is gout. The prevalence has risen during the past few decades, according to numerous research. In the past 20 years, oral urate-lowering medications have treated approximately a third of the more than nine million gout sufferers. Furthermore, due to rising regulatory approval of the medicines recommended for gout disease treatment, the Europe gout therapy market is anticipated to experience considerable expansion over the projected period.

Discover More Research Reports on Healthcare Industry by Market Research Future:
Microarray Analysis Market Research Report Information By Product & Services (Consumables, Software and Services), By Type (DNA Microarrays and Protein Microarrays), By Application (Drug Discovery, Disease Diagnostic and Research Applications), By End User (Pharmaceutical and Biotechnology Companies, Research and Academic Institutes, Diagnostic Laboratories), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

Organ Preservation Market Research Report By Solution (University of Wisconsin Solution, Custodial HTK, Collins Solution, Celsior Solution, Perfadex, Citrate Solution), By Preservation Techniques (Static Cold Storage, Dynamic Cold Storage) By Organ Type (Kidney, Liver, Heart, Lungs), By End User (Hospitals & Clinics, Organ Banks), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

Stem Cell Therapy Market Research Report Information By Cell Source (Adipose Tissue, Bone Marrow, Neural, Embryo/Cord Blood-Derived, IPSCs, PPSCs), By Type (Allogenic, Autologous), by Application (Cancer, Diabetes, MusculoskeletalDisorders, Cardiovascular, Gastrointestinal Diseases,Others), By End Users (Hospitals & Clinics, Ambulatory Surgical Centers (ASCs), Academic and Research Centers,Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032.

Corporate Wellness Market Research Report Information by Service (Health Risk Assessment, Fitness, Smoking Cessation, Biometric Screening, Nutrition & Weight Management, Stress Management, Alcohol & Drug Abuse Services, and Others), by Category (Fitness & Nutrition Consultants, Psychological Therapists, and Organizations), by End User (Small-Scale Organizations, Medium-Scale Organizations, and Large-Scale Organizations), and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2030

Compression Therapy Market Research Report Information By Technique (Static and Dynamic), By Product (Compression Garments, Compression Pump and Compression Braces), By Application (Varicose Vein, Deep Vein Thrombosis, Lymphedema and Leg Ulcer), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow UsLinkedIn | Twitter

Tags: , , , , , , , ,

See Campaign:

Contact Information:

Contact: Market Research Future (Part of Wantstats Research and Media Private Limited) 99 Hudson Street, 5Th Floor New York, NY 10013 United States of America +1 628 258 0071 (US) +44 2035 002 764 (UK) Email: [email protected] Website:


Research Newswire, English